www.novozymes.com

About our technologies

Innovative science and a strong IP portfolio drives Novozymes' technologies platforms.

As the world leaders in yeast based protein expression, we bring over 45 years worth of experience in industrial scale recombinant protein production to the bipharmaceutical industry.

 

Yeast based protein expression

The gold standard in microbial protein expression

 

Yeast based expression technology

Antibody fragment expression

AlbufuseTM, albumin fusion technology

Effective half-life extension of protein drugs

 

AlbufuseTM, albumin fusion technology

 

 

For further information or to discuss how our technologies can help you and your application, email us at biopharma@novozymes.com.

 
 
 

AlbufuseTM: Proven Enhancement

 

AlbufuseTM technology is proven to enhance active molecules in a range of pre-clinical studies and is being clinically evaluated in human therapeutic applications.

 
 

Related Product Information

 
Technologies
Protein expression
Albumin fusion
Home
Recombinant products
Technologies
Services
Industrial benefits
About us
Info centre
Contact
 
Novozymes A/S - Krogshøjvej 36 - 2880 Bagsværd - Denmark - Tel. +45 4446 0000 - biopharma@novozymes.com